Clinical Trial Update: Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris [Phase 2]

View source ↗

Summary

The update notes the completion of a Phase II trial of RA-18C3 in adults with moderate to severe acne vulgaris. The snippet does not provide efficacy or safety …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• RA-18C3

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED